Overtreatment of COPD with Inhaled Corticosteroids - Implications for Safety and Costs: Cross-Sectional Observational Study

INTRODUCTION: Combined inhaled long-acting beta-agonists and corticosteroids (LABA+ICS) are costly. They are recommended in severe or very severe chronic obstructive pulmonary disease (COPD). They should not be prescribed in mild or moderate disease. In COPD ICS are associated with side-effects incl...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Patrick, Thornton, Hannah, Pinnock, Hilary, Georgopoulou, Sofia, Booth, Helen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806778/
https://www.ncbi.nlm.nih.gov/pubmed/24194824
http://dx.doi.org/10.1371/journal.pone.0075221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806778/
https://www.ncbi.nlm.nih.gov/pubmed/24194824
http://dx.doi.org/10.1371/journal.pone.0075221

Ejemplares similares